January 7, 2019
Debiopharm breaks up with Allergan over Trelstar sale in Nort America
Swiss-based global biopharmaceutical company Debiopharm Group will break up partnership with Allergan, and will transfer commercialisation licence for Trelstar in the US and Canada.